This patent covers novel vectors for generating fusion proteins comprising one or more regions of the human albumin protein. The patent covers specific nucleotide sequences and most notable albumin-G-CSF fusions that have 5 times longer self life as compared to unmodified G-CSF and at least 3 fold longer half life in plasma.
This patent is useful for entities seeking the generate recombinant proteins for in vivo administration.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.